Comparison of the Effectiveness of Low-Dose Indinavir/Ritonavir (IDV/r)- versus Atazanavir/Ritonavir (ATV/r)-Based Generic Antiretroviral Therapy in NNRTI-Experienced HIV-1-Infected Patients in India.

@article{Patel2011ComparisonOT,
  title={Comparison of the Effectiveness of Low-Dose Indinavir/Ritonavir (IDV/r)- versus Atazanavir/Ritonavir (ATV/r)-Based Generic Antiretroviral Therapy in NNRTI-Experienced HIV-1-Infected Patients in India.},
  author={Atul K Patel and Ketan K. Patel and E. Ramakrishna Naik and Jingyi Duan and Rajiv Ranjan and Jagdish K. Patel and Hamisu M. Salihu},
  journal={Journal of the International Association of Physicians in AIDS Care},
  year={2011},
  volume={10 2},
  pages={111-8}
}
BACKGROUND Currently, data on the effectiveness of second-line antiretroviral regimens using indinavir/ritonavir (IDV/r) and atazanavir/ritonavir (ATV/r) along with 2 nucleoside reverse transcriptase inhibitor (NRTI) in resource-poor settings is limited. METHODS Observational follow-up study on 441 patients who experienced treatment failure to first-line… CONTINUE READING